{"filing":{"accession_number":"0001628280-26-061326","cik":"0001818093","ticker":"SKIN","company_name":"SkinHealth Systems Inc.","form":"8-K","filing_date":"2026-09-10","report_date":"2026-09-03","primary_document":"skin-20260903.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1818093/000162828026061326/skin-20260903.htm"},"events":[{"id":32636,"run_id":29998,"accession_number":"0001628280-26-061326","anchor_item_number":"5.02","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.72,"summary":"While the disclosure centers on Michael Monahan's promotion to Chief Financial and Operating Officer (effective September 3, 2026), the substantive disclosure is the associated compensation change: his base salary increase from $515,000 to $555,000 effective September 15, 2026. The promotion itself is a role expansion, but the filing emphasizes the compensatory arrangement modification. This is material as it reflects a material change in executive compensation tied to expanded responsibilities.","company_name":"SkinHealth Systems Inc.","ticker":"SKIN","filing_date":"2026-09-10","form":"8-K","submitted_at":null,"items":[{"id":35853,"accession_number":"0001628280-26-061326","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.72,"reasoning":"While the disclosure centers on Michael Monahan's promotion to Chief Financial and Operating Officer (effective September 3, 2026), the substantive disclosure is the associated compensation change: his base salary increase from $515,000 to $555,000 effective September 15, 2026. The promotion itself is a role expansion, but the filing emphasizes the compensatory arrangement modification. This is material as it reflects a material change in executive compensation tied to expanded responsibilities.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-10T20:09:08.498792+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":35853,"accession_number":"0001628280-26-061326","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.72,"reasoning":"While the disclosure centers on Michael Monahan's promotion to Chief Financial and Operating Officer (effective September 3, 2026), the substantive disclosure is the associated compensation change: his base salary increase from $515,000 to $555,000 effective September 15, 2026. The promotion itself is a role expansion, but the filing emphasizes the compensatory arrangement modification. This is material as it reflects a material change in executive compensation tied to expanded responsibilities.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-10T20:09:08.498792+00:00","company_name":"SkinHealth Systems Inc.","ticker":"SKIN","filing_date":"2026-09-10"}]}